inclusion criteria: 1. patients of both sexes, older than 18 years of age, with sars-cov-2 infection confirmed in upper or lower respiratory tract secretion, through reverse transcription followed by polymerase chain reaction (rt- pcr), with mild or moderate manifestations of covid-19, who wish to participate, and consent by signing the informed consent form and not involved in another clinical trial during the study period 2. pneumonia assessed clinically and / or radiologically will not be mandatory for inclusion 3. have a telephone (cellular or landline) that may be available to receive daily calls throughout the study period. 4. willingness to voluntarily participate in the study to accept randomization for either treatment arm. 5. signing of the approved free and informed consent form (icf) by the research ethics committee (cep) and conep

inclusion criteria: 1. patients of both sexes, older than 18 years of age, with sars-cov-2 infection confirmed in upper or lower respiratory tract secretion, through reverse transcription followed by polymerase chain reaction (rt- pcr), with mild or moderate manifestations of covid-19, who wish to participate, and consent by signing the informed consent form and not involved in another clinical trial during the study period 2. pneumonia assessed clinically and / or radiologically will not be mandatory for inclusion 3. have a telephone (cellular or landline) that may be available to receive daily calls throughout the study period. 4. willingness to voluntarily participate in the study to accept randomization for either treatment arm. 5. signing of the approved free and informed consent form (icf) by the research ethics committee (cep) and conep

inclusion criteria: patients of both sexes, older than 18 years of age, with sars-cov-2 infection confirmed in upper or lower respiratory tract secretion, through reverse transcription followed by polymerase chain reaction (rt- pcr), with mild or moderate manifestations of covid-19, who wish to participate, and consent by signing the informed consent form and not involved in another clinical trial during the study period pneumonia assessed clinically and / or radiologically will not be mandatory for inclusion have a telephone (cellular or landline) that may be available to receive daily calls throughout the study period. willingness to voluntarily participate in the study to accept randomization for either treatment arm. signing of the approved free and informed consent form (icf) by the research ethics committee (cep) and conep

inclusion criteria: patients of both sexes, older than 18 years of age, with sars-cov-2 infection confirmed in upper or lower respiratory tract secretion, through reverse transcription followed by polymerase chain reaction (rt- pcr), with mild or moderate manifestations of covid-19, who wish to participate, and consent by signing the informed consent form and not involved in another clinical trial during the study period pneumonia assessed clinically and / or radiologically will not be mandatory for inclusion have a telephone (cellular or landline) that may be available to receive daily calls throughout the study period. willingness to voluntarily participate in the study to accept randomization for either treatment arm. signing of the approved free and informed consent form (icf) by the research ethics committee (cep) and conep

inclusion criteria: 1. patients of both sexes, older than 18 years of age, with sars-cov-2 infection confirmed in upper or lower respiratory tract secretion, through reverse transcription followed by polymerase chain reaction (rt- pcr), with mild or moderate manifestations of covid-19, who wish to participate, and consent by signing the informed consent form and not involved in another clinical trial during the study period 2. pneumonia assessed clinically and / or radiologically will not be mandatory for inclusion 3. have a telephone (cellular or landline) that may be available to receive daily calls throughout the study period. 4. willingness to voluntarily participate in the study to accept randomization for either treatment arm. 5. signing of the approved free and informed consent form (icf) by the research ethics committee (cep) and conep

inclusion criteria: 1. patients of both sexes, older than 18 years of age, with sars-cov-2 infection confirmed in upper or lower respiratory tract secretion, through reverse transcription followed by polymerase chain reaction (rt- pcr), with mild or moderate manifestations of covid-19, who wish to participate, and consent by signing the informed consent form and not involved in another clinical trial during the study period 2. pneumonia assessed clinically and / or radiologically will not be mandatory for inclusion 3. have a telephone (cellular or landline) that may be available to receive daily calls throughout the study period. 4. willingness to voluntarily participate in the study to accept randomization for either treatment arm. 5. signing of the approved free and informed consent form (icf) by the research ethics committee (cep) and conep